| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040825543 |
| P356 | DOI | 10.1007/S00066-012-0154-8 |
| P698 | PubMed publication ID | 22911239 |
| P2093 | author name string | Nieder C | |
| P2860 | cites work | Why current publication practices may distort science | Q21563409 |
| Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma | Q22306235 | ||
| ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2 | Q24647310 | ||
| WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis | Q24650922 | ||
| Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses | Q24677973 | ||
| Chromosome breakage after G2 checkpoint release | Q24683383 | ||
| A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck | Q25255831 | ||
| A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. | Q27919669 | ||
| Ewing's sarcoma family of tumors: current management | Q28242009 | ||
| Signalling via integrins: implications for cell survival and anticancer strategies | Q28272370 | ||
| Exploring the role of cancer stem cells in radioresistance | Q28282037 | ||
| Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial | Q28285969 | ||
| Respiration tracking in radiosurgery | Q28293279 | ||
| New antiemetic drugs | Q28306717 | ||
| Pathways of DNA double-strand break repair during the mammalian cell cycle | Q28608969 | ||
| CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. | Q30336279 | ||
| Positron emission tomography for radiation treatment planning | Q30996584 | ||
| O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study | Q31395282 | ||
| Results of carbon ion radiotherapy in 152 patients | Q33272024 | ||
| Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas | Q33272795 | ||
| Helical tomotherapy. Experiences of the first 150 patients in Heidelberg | Q33273022 | ||
| Particle radiation therapy using proton and heavier ion beams | Q33277800 | ||
| Characteristics associated with citation rate of the medical literature | Q33283512 | ||
| Effectiveness of journal ranking schemes as a tool for locating information | Q33321241 | ||
| Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's | Q33349465 | ||
| Impact of the impact factor in biomedical research: its use and misuse | Q33497349 | ||
| Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells | Q33604925 | ||
| Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion | Q47818877 | ||
| Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. | Q47824845 | ||
| Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation | Q48331995 | ||
| Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases | Q48350215 | ||
| Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer | Q48623725 | ||
| Four-dimensional computed tomography: image formation and clinical protocol. | Q51465980 | ||
| Number and orientations of beams in intensity-modulated radiation treatments. | Q51648661 | ||
| Bibliometric indicators: quality measurements of scientific publication. | Q51702608 | ||
| Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. | Q51888575 | ||
| Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. | Q52068692 | ||
| Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. | Q52070616 | ||
| Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. | Q52142739 | ||
| Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis | Q52329318 | ||
| Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. | Q53256954 | ||
| Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. | Q53814690 | ||
| The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. | Q55044969 | ||
| Endoluminal Beta-Radiation Therapy for the Prevention of Coronary Restenosis after Balloon Angioplasty | Q57908164 | ||
| Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. | Q65000521 | ||
| Methods of image reconstruction from projections applied to conformation radiotherapy | Q68608507 | ||
| Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma | Q71626609 | ||
| Prognosis and treatment of disseminated uveal melanoma | Q72526915 | ||
| Phase III randomized trial of amifostine as a radioprotector in head and neck cancer | Q73025273 | ||
| Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis | Q73073993 | ||
| Pathological features of rectal cancer after preoperative radiochemotherapy | Q73251040 | ||
| Stereotactic single-dose radiotherapy of stage I non–small-cell lung cancer (NSCLC) | Q73371647 | ||
| Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response | Q73661195 | ||
| Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial | Q73677933 | ||
| Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results | Q74462365 | ||
| Stereotactic radiotherapy of targets in the lung and liver | Q77483854 | ||
| 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis | Q77811636 | ||
| Influence of the hypoxic subvolume on the survival of patients with head and neck cancer | Q77936400 | ||
| Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial | Q79202551 | ||
| Do erythropoietin receptors on cancer cells explain unexpected clinical findings? | Q79209551 | ||
| Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer | Q79460548 | ||
| Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients | Q80508498 | ||
| Colorectal cancer | Q81244694 | ||
| Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer | Q81323824 | ||
| [Update S3-guideline "colorectal cancer" 2008] | Q81899161 | ||
| Normalized impact factor (NIF): an adjusted method for calculating the citation rate of biomedical journals | Q82459175 | ||
| Author self-citation in the general medicine literature | Q33940967 | ||
| Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. | Q34206288 | ||
| Endostatin's antiangiogenic signaling network | Q34306081 | ||
| European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). | Q34342158 | ||
| Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease | Q34534439 | ||
| Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. | Q34537954 | ||
| Preoperative versus postoperative chemoradiotherapy for rectal cancer | Q34552041 | ||
| Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference | Q34562944 | ||
| Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction | Q34603020 | ||
| Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma | Q34623144 | ||
| European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. | Q34735176 | ||
| Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). | Q34742742 | ||
| Hyperthermia in combined treatment of cancer | Q34766163 | ||
| ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin | Q34801409 | ||
| International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations | Q35164084 | ||
| DNA damage checkpoint control in cells exposed to ionizing radiation | Q35208818 | ||
| Imaging oxygenation of human tumours | Q35676947 | ||
| Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer | Q35757054 | ||
| Tumor microenvironmental physiology and its implications for radiation oncology | Q35837012 | ||
| Relative citation impact of various study designs in the health sciences | Q36130841 | ||
| Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. | Q36403334 | ||
| ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. | Q36477266 | ||
| American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. | Q36485520 | ||
| Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma | Q36969748 | ||
| European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. | Q37055475 | ||
| Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia | Q37100060 | ||
| Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin | Q37261069 | ||
| Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany | Q37708665 | ||
| Combined-modality treatment for anal cancer: current strategies and future directions | Q37768039 | ||
| The use of FDG-PET to target tumors by radiotherapy | Q37785001 | ||
| The value of lesser-impact-factor surgical journals as a source of negative and inconclusive outcomes reporting | Q37832626 | ||
| kV cone-beam CT-based IGRT: a clinical review. | Q37870806 | ||
| Stereotactic radiotherapy in the liver hilum. Basis for future studies | Q37970957 | ||
| Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. | Q39528189 | ||
| gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization | Q39742371 | ||
| 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair | Q39750906 | ||
| Temozolomide preferentially depletes cancer stem cells in glioblastoma | Q39960750 | ||
| Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy | Q40006232 | ||
| Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others | Q40053401 | ||
| Scientific collaboration results in higher citation rates of published articles | Q40323359 | ||
| Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase | Q40401323 | ||
| Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. | Q40414453 | ||
| Cellular basis of radiation-induced fibrosis | Q40418343 | ||
| ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation | Q40570996 | ||
| A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity | Q40595505 | ||
| Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor | Q40871068 | ||
| Statistical validation of a global model for the distribution of the ultimate number of citations accrued by papers published in a scientific journal | Q41870112 | ||
| Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. | Q43543641 | ||
| Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. | Q43694213 | ||
| Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer | Q44155882 | ||
| Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer | Q44547446 | ||
| PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy | Q44598666 | ||
| Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials | Q44730385 | ||
| Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. | Q44776010 | ||
| Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment | Q44780586 | ||
| Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. | Q44796944 | ||
| Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. | Q45254017 | ||
| Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera | Q45271712 | ||
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
| Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus | Q46412803 | ||
| Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. | Q46639252 | ||
| Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification | Q46770169 | ||
| Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer | Q46772390 | ||
| Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy | Q46882519 | ||
| [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck | Q46897615 | ||
| The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. | Q46984864 | ||
| Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. | Q47200237 | ||
| Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study | Q47746681 | ||
| P433 | issue | 10 | |
| P921 | main subject | citation analysis | Q206276 |
| radiation oncology | Q729267 | ||
| collaboration | Q1145523 | ||
| research collaboration | Q58327774 | ||
| P304 | page(s) | 865-872 | |
| P577 | publication date | 2012-08-23 | |
| P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
| P1476 | title | Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity | |
| P478 | volume | 188 |
| Q30486243 | Correlation between article download and citation figures for highly accessed articles from five open access oncology journals |
| Q38099657 | Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles |
| Q33967649 | Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns |
| Q38374871 | Scientific impact of studies published in temporarily available radiation oncology journals: a citation analysis |
Search more.